Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Light-Activated Antimicrobial Surface Also Works in the Dark

Published: Tuesday, March 25, 2014
Last Updated: Tuesday, March 25, 2014
Bookmark and Share
The new antibacterial material, developed by researchers at UCL, has potential for cutting hospital acquired infections.

The combination of two simple dyes with nanoscopic particles of gold is deadly to bacteria when activated by light - even under modest indoor lighting. And in a first for this type of substance, it also shows impressive antibacterial properties in total darkness.

The research, from by Sacha Noimark and Ivan Parkin (both UCL Chemistry) and Elaine Allan (UCL Eastman Dental Institute), is published today in the journal Chemical Science.

Hospital-acquired infections are a major issue for modern medicine, with pathogens like methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile (C. diff) getting extensive publicity. Although medical establishments have stringent cleaning policies, insist on frequent hand-washing by staff, and have powerful drugs at their disposal, it is difficult to eliminate these infections unless you can make the hospital environment more hostile to microbes. Surfaces, such as door handles, medical equipment, keyboards, pens and so on are an easy route for germs to spread, even onto freshly-cleaned hands.

One possible solution to this is to develop alternative strategies such as antibacterial coatings that make surfaces less accommodating to germs. These surfaces are not like antibacterial fluids that just wash away - the goal is to make a surface which is intrinsically deadly to harmful bacteria.

 “There are certain dyes that are known to be harmful to bacteria when subjected to bright light,” explains the study’s corresponding author Ivan Parkin (Head of UCL Chemistry). “The light excites electrons in them, promoting the dye molecules to an excited triplet state and ultimately produces highly reactive oxygen radicals that damage bacteria cell walls. Our project tested new combinations of these dyes along with gold nanoparticles, and simplified ways of treating surfaces which could make the technology easier and cheaper to roll out.”

The team, tested several different combinations of the dyes crystal violet (already used to treat staph infections), methylene blue and nanogold, deposited on the surface of silicone. This flexible rubbery substance is widely used as a sealant, a coating and to build medical apparatus such as tubes, catheters and gaskets, and can also be used as protective casings for things like keyboards and telephones.

While work to create antimicrobial surfaces in the past has often concentrated on complex ways of bonding dyes to the surface, this study took a simpler approach. The researchers used an organic solvent to swell the silicone, allowing the methylene blue and gold nanoparticles to diffuse through the polymer. They then dipped the silicone into a crystal violet solution to form a thin dye layer at the polymer surface.

In their tests, in which infected surfaces were subjected to light levels similar to those measured in hospital buildings, surfaces treated with a combination of crystal violet, methylene blue and nanogold showed the most potent bactericidal effect ever observed in such a surface. Moreover, the treatment did not significantly change the properties of the silicone (for instance, how water repellent it is), and the coating was not affected by rubbing with alcohol wipes, meaning it can stand up to the repeated cleaning that goes on in hospitals, without being worn off.

“Despite contaminating the surface with far more bacteria than you would ever see in a hospital setting, placed under a normal fluorescent light bulb, the entire sample was dead in three to six hours, depending on the type of bacteria,” says the paper’s lead author, Sacha Noimark. “That was an excellent result, but the bigger surprise was the sample which we left in the dark. That sample too showed significant reductions in bacterial load, albeit over longer timescales of about three to eighteen hours. The precise mechanism by which this dark-kill works is not yet clear, though.” 

This is the first time a light-activated antimicrobial surface has had any kind of effect in the dark. This, along with its unprecedented performance under hospital lighting conditions, and relatively simple and cost-effective manufacture, means that the technology is extremely promising for future applications.

The team have been granted a patent on the formulation. The work was sponsored through the UCL M3S engineering doctorate centre and co-funded by Ondine Biopharma.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Orchard Therapeutics Launched
UCL and F-Prime launch Orchard Therapeutics to treat rare childhood diseases.
Wednesday, May 04, 2016
Activating Cancer-Killing Immune Cells
A UCL research team have discovered that cutting off a sleep-switch on immune cells inside a tumour wakes up the cells and enables the immune system to hunt down and destroy cancer.
Tuesday, April 19, 2016
Cancer Drug Could Treat Blood Vessel Deformities
A drug currently being trialled in cancer patients could also be used to treat an often incurable condition that can cause painful blood vessel overgrowths inside the skin.
Monday, April 04, 2016
First Gene for Grey Hair Found
The first gene identified for greying hair has been discovered by an international UCL-led study, confirming greying has a genetic component and is not just environmental. - See more at: https://www.ucl.ac.uk/news/news-articles/0316/010316-first-grey-hair-gene-discovered#sthash.gD0shNNC.dpuf
Thursday, March 03, 2016
New Biomarker to Assess Stem Cells Developed
A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.
Wednesday, February 03, 2016
UCL Launches £50 million Technology Investment Fund
UCL is today launching the UCL Technology Fund to invest £50 million in commercialising its world-leading research emerging over the next five years.
Monday, January 25, 2016
DNA ‘Building Blocks’ Pave the Way for Improved Drug Delivery
DNA has been used as a ‘molecular building block’ to construct synthetic bio-inspired pores which will improve the way drugs are delivered and help advance the field of synthetic biology, according to scientists from UCL and Nanion Technologies.
Tuesday, January 19, 2016
First Human Trial for Huntington's Drug
Patients in London are being dosed for the first time with an experimental drug for Huntington’s disease.
Thursday, October 22, 2015
Genes Involved in Schizophrenia and Obesity Highlighted
Genes involved in schizophrenia and obesity have been highlighted in a new UCL study, which could lead to a better understanding of the DNA variants which affect risk of these conditions and aid the development of improved strategies for prevention and treatment.
Monday, October 19, 2015
Possible Evidence for Human Transmission of Alzheimer’s Pathology
Study suggests that under a particular set of circumstances, amyloid-ß may potentially be transmissible through certain medical procedures.
Friday, September 11, 2015
New Variant of Streptococcal Bacteria
Scientists have discovered a new variant of streptococcal bacteria that has contributed to a rise in disease cases in the UK over the last 17 years.
Wednesday, July 15, 2015
Smoking Signs
Research reveals epigenetic alterations caused by smoking.
Wednesday, May 20, 2015
New Biomarkers To Spot Pancreatic Cancer Early
A combination of two biomarkers can identify pre-clinical pancreatic cancer.
Thursday, February 05, 2015
Autolus Launches With £30m Investment
UCL cancer immunotherapy company, Autolus is launches to develop T-cell therapies for haematological and solid tumours.
Thursday, January 22, 2015
Raman Spectroscopy May Enable Non-Invasive Diagnosis of Bone Diseases
Detection of a genetic ‘brittle bone’ disease known as Osteogenesis Imperfecta (OI) is possible by simply scanning a patient’s limbs.
Wednesday, December 03, 2014
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Blood Pressure Drug May Boost Effectiveness of Lung Cancer Treatment
Researchers at Imperial College London have suggested that the blood pressure drug may make a type of lung cancer treatment more effective.
Insight into Eye Diseases
Scientists recreate zebrafish cell regeneration from retinal stem cells in mice.
New Discovery May Benefit Farmers Worldwide
Scientists have shown how a crop-microbe 'team' protect against fungal infection.
Antibodies Paving the Way to HIV Vaccine
Researchers uncover factors responsible for the formation of broadly neutralizing HIV antibodies in humans.
Designing Drugs with a Whole New Toolbox
Researchers develop methods to design small, targeted proteins with shapes not found in nature.
Protein Studies Discover Molecular Secrets
Two protein studies have mapped proteins that reveal the secrets to recycling carbon and healing cells.
Tapping Evolution to Improve Biotech Products
Researchers show how 'ancestral sequence reconstruction' can be used to guide engineering of a blood clotting protein.
Vaccine Against Common Cold Achievable
Researchers suggest that a vaccine against rhinoviruses is possible using variant virus vaccines.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!